A hybrid multistage protein vaccine induces protective immunity against murine malaria - Wikidata - awgldk - TriplyDB

A hybrid multistage protein vaccine induces protective immunity against murine malaria

A hybrid multistage protein vaccine induces protective immunity against murine malaria

http://www.wikidata.org/entity/Q28730779

about

Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35 Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mi A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.

P2860

Q34078790-6AC4FCC3-A952-4732-99EB-7AEAC5B54CC3 Q35947469-16E28466-3C75-46D0-B312-F9F9358DC73E Q36003208-38E87DE7-8829-4CD9-BBB6-21CE17D60065 Q36178611-01BFDD9B-1A49-4486-9A97-B182DA332985 Q36646698-F9431C64-48B3-4783-856C-11E9CD6F37C9 Q37314756-080D591A-CE93-4581-B225-2194D1B5BE0F Q39441716-486F6D0E-A6A1-460B-9C74-3E2C6617B0D1 Q40210139-C863E445-0AF9-4ED3-9F57-D4E30A3D4639

P2860

A hybrid multistage protein vaccine induces protective immunity against murine malaria

http://www.wikidata.org/entity/Q28730779

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@ast

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@en

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@nl

type

label

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@ast

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@en

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@nl

prefLabel

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@ast

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@en

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@nl

P1433

Q28730779-B2474E89-EF29-4AE9-924F-BE96DC8FBA7F

P1476

Q28730779-D3247F5F-5DCB-49E3-9CC0-002EDE1CCFF8

P2093

Q28730779-05804E9D-A481-4C07-8D72-49EFDF4A28DE

Q28730779-1B66031C-6A1A-4011-BB8F-8B0EF031976E

Q28730779-BEC8B1BD-3F89-4DDD-9049-17F6437A3C20

Q28730779-C66444DD-A384-44A5-B0AC-0677AC4DFDE5

P2860

Q28730779-0267AA04-2F2B-475F-BA51-FAB016C664BE

Q28730779-04437A5E-BE5B-4E99-B82A-862D7D703B6C

Q28730779-23B4A8EE-2570-4A6F-9B4D-39EA2E258C60

Q28730779-2C4B75B3-36EA-46DC-A9E7-21D1027B2E8D

Q28730779-2FC7C220-1A7A-408D-B095-8622153762F6

Q28730779-337F6FE7-5147-44CB-B125-FC438CE977D9

Q28730779-36FFE70E-C172-4421-924F-4E664C1B9A48

Q28730779-37BC9B6D-0CA7-41FE-A9E1-8D5321EBCA50

Q28730779-3E5115DD-A7DE-43D3-A5DE-D32DB1C7577D

Q28730779-435CBEE1-99F0-43AC-9E11-FE3BD382E95E

P304

Q28730779-76911273-8BB5-4343-8DA4-E979F44C783B

P31

Q28730779-49DAE7CE-1937-4885-8399-3AD604C5725B

P3181

Q28730779-F7FB3961-836D-4473-9E86-E9FDA84E1680

P356

Q28730779-EAB7A94E-A6B6-4D98-B6BF-22FCA05D1C20

P407

Q28730779-DE095DA6-C0EF-4040-AEC5-39325A6A185B

P433

Q28730779-DEA6CBAE-08C0-4F35-AB06-5E6D2340D947

P478

Q28730779-71FCB4B8-7AD0-49BF-BC3A-E5A9D5E34D93

P577

Q28730779-505B36D4-D367-4E5F-8106-C15FDB892444

P5875

Q28730779-F162943E-E85C-4E16-AB93-7F446325D33F

P698

Q28730779-A270E5F6-524C-45A2-AEF5-E1A53B0149B1

P921

Q28730779-D83B70D5-9CFB-41E5-BE55-3CF0EB7BE3BB

Q28730779-D8CAD503-EE71-46B2-8F77-6F7AE0EAEE76

P932

Q28730779-97F6CA61-76F7-44FB-98FC-5655E39EE33F

P3181

P356

P1433

Infection and Immunity

P1476

A hybrid multistage protein vaccine induces protective immunity against murine malaria

@en

P2093

Alberto Moreno

http://www.w3.org/2001/XMLSchema#string

Balwan Singh

http://www.w3.org/2001/XMLSchema#string

Jianlin Jiang

http://www.w3.org/2001/XMLSchema#string

Monica Cabrera-Mora

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate

Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate

The RTS,S malaria vaccine

T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines

Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

T-cell quality in memory and protection: implications for vaccine design

Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression.

CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.

P304

1491-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1995447

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/IAI.05980-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221754816

http://www.w3.org/2001/XMLSchema#string

P698

22252877

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3318412

http://www.w3.org/2001/XMLSchema#string